Gastroenterology Research and Practice / 2009 / Article / Tab 3

Clinical Study

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

Table 3

Short form 36, SF-36 (100% Best).

( )1st year2nd year

BaselineWeek 13Week 26Week 52WashoutWeek 13Week 26Week 52P-value

TreatmentNoneGLP-2GLP-2GLP-2NoneGLP-2GLP-2 + Cholyl-sarcosineGLP-2
Physical Function 0.51
Limitation based on Physical Function 0.34
Physical Pain 0.19
General Well-being 0.84
Physical Component Summary 0.83
Energy 0.10
Social Function 0.44
Limitation based on Mental Function 0.28
Mental Function * * * * * 0.02
Mental Component Summary * 0.02

* Compared to Baseline by Dunnett’s alternatively Bonferoni’s test.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.